Skip to main content

Total Knee Arthroplasty clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • Dexamethasone in Total Knee Arthroplasty

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the most efficacious and safest dexamethasone dose given intraoperatively during total knee arthroplasty that reduces postoperative opioid consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications.

    at UCSF

  • Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System

    open to eligible people ages 21 years and up

    The purpose of this study is to gather information about how knee pain changes when small amounts of electricity are delivered to the nerves in the leg. This study will involve the use of a Peripheral Nerve Stimulation (PNS) System that is made by SPR Therapeutics (the sponsor of the study). The SPRINT PNS System was cleared by the FDA for up to 60 days of use in the back and/or extremities for the management of acute and chronic pain.

    at UCSD

Our lead scientists for Total Knee Arthroplasty research studies include .

Last updated: